<DOC>
	<DOCNO>NCT00001487</DOCNO>
	<brief_summary>Dehydroepiandrosterone ( DHEA ) hormone produce adrenal gland . As human grow old level DHEA naturally decrease . Low level DHEA associate variety harmful effect , include increased heart disease , decrease immune system function , decrease bone density ( osteoporosis ) , high cholesterol , increase fat muscle ratio . Blood level DHEA sulfate form , DHEA-S , begin drop human 20 's . By time human 40 's 50 's , level DHEA DHEA-S level 50 % peak . Previous study show level hormone associate feeling `` well-being '' enjoyment `` leisure '' activity . In study researcher interested effect mood behavior DHEA men woman mid-life related mood disorder . Specifically , researcher would like find increasing level DHEA lessen symptom associate disorder .</brief_summary>
	<brief_title>Treatment Mid-Life-Related Mood Disorders</brief_title>
	<detailed_description>Dehydroepiandrosterone ( DHEA ) hormone produce adrenal gland concentration decrease age . In human low DHEA level associate variety adverse biological consequence , include increase cardiovascular disease , decrease immune function , decrease bone density , negative lipid profile increase fat muscle ratio . In study , investigate effect mood behavior DHEA men woman midlife-related mood disorder double-blind , placebo-controlled , crossover trial . We specifically ask whether increase DHEA level mitigate neurasthenia-like symptom characteristic disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>INCLUSION CRITERIA : Subjects study meet follow criterion : A current episode minor ( meet 34 criterion symptom ) major depression moderate severity less SCID severity scale depression meeting DSMIV criterion symptom # 9 ( suicide ) determine administration minor depression module SADSL Structured Clinical Interview DSMIV . Additionally , ensure subject meet minimum threshold severity depression , subject score great equal 10 either Beck Depression Inventory ( BDI ) Center Epidemiologic Studies Depression ( CESD ) Scale least three four clinic visit two month screen phase . Subjects exclude meet follow criterion : major depression great moderate severity , DSMIV criterion # 9 ( suicide ) , anyone require immediate treatment clinical assessment , functional impairment rating five six seven consecutive day daily rating ; Age 4065 ; No prior hormonal therapy treatment menopause/andropauserelated mood physical symptom within last six month ; In good medical health . EXCLUSION CRITERIA : The following condition constitute contradiction treatment DHEA preclude subject 's participation protocol : Positive ( threshold ) response SCID major depression section item # 9 , suicidal ideation ; Anyone require immediate treatment clinical assessment ; Severity rating great moderate SCID ; Functional impairment rating five six seven consecutive day daily rating Current treatment antidepressant medication Prostate nodule cancer Moderate symptom benign prostatic hypertrophy hesitancy , urgency , frequent void feel incomplete void History ischemic cardiac disease Renal disease Hepatic dysfunction Women history carcinoma breast , woman family history following : premenopausal breast cancer bilateral breast cancer first degree relative ; multiple family member ( great three relative ) postmenopausal breast cancer Women history uterine cancer Patients know hypersensitivity DHEA androgens Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Andropause</keyword>
	<keyword>Depression</keyword>
	<keyword>DHEA</keyword>
	<keyword>Steroids</keyword>
	<keyword>Mid-Life Depression</keyword>
	<keyword>Mid Life</keyword>
	<keyword>Perimenopause</keyword>
	<keyword>Climecteric-Related Mood Disorder</keyword>
</DOC>